US pharmaceutical giant Pfizer concluded its second sell-down in its consumer healthcare spin-off, Haleon. It raised £2.432bn ($3.25bn) by selling 43bn of shares in an accelerated bookbuild, which was ...

Oil prices jumped and stocks tumbled on Tuesday after Iran fired more than a hundred missiles at Israel in retaliation for ...

Following a similar move in March, Pfizer is offloading another tranche of Haleon shares. | Pfizer has sold 640 million ...

Pfizer sold a stake in British consumer healthcare group Haleon worth about $3.26 billion on Monday, cutting its shareholding ...

The latest health news highlights include Kailera Therapeutics' $400 million funding, potential CVS Health restructuring, ...

Ford Motor Co said on Tuesday it will lower the annual and monthly subscription prices for its hands-free driving technology.

THE DIVERSITY Network Awards 2024, proudly headlined by Haleon, took place for the first time at the InterContinental London ...

Haleon PLC, leading to a significant share repurchase.,UBS has reaffirmed its positive rating on Haleon following this ...

Meanwhile, "gold prices ticked higher, within sight of record highs amid the Middle East turmoil, helping to lift precious metals miners on the UK stock market", Mould added. Gold was quoted at ...

Pfizer has offloaded a £2.43billion stake in consumer health spin-out Haleon, which said it would buy back £230million of the ...

Pfizer (PFE) reduces its stake in Haleon to 15% from 22.6% by selling £2.45B worth of shares, continuing its gradual ...

Pfizer has divested a $3.3 billion stake in Haleon, reducing its holding in the British consumer healthcare company.